LatestNovo Nordisk Expands Obesity Treatment Strategy and Direct-to-Consumer Approach
Cannabis

Water Hash Jar Test: Selecting the Right Cannabis Strains for Ice Water Extraction

Water Hash Jar Test: Selecting the Right Cannabis Strains for Ice Water Extraction
Summary

Not all cannabis strains are suitable for water hash extraction, even if they perform well when smoked. Fresh frozen plant material (WPFF extracts) requires special consideration, as live resin behaves differently than dried material, making extraction and collection more challenging. Understanding strain genetics and plant characteristics is essential for selecting varieties that yield quality water hash concentrates. This distinction helps medical cannabis patients and producers optimize extraction methods for their therapeutic needs.

Originally published on

Soft Secrets (Español)

Read full article(opens in new tab)

Fetched: September 21, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Minor Cannabinoids: Commercial Promises vs. Scientific Evidence
Cannabis
AnxietyDepression

Minor Cannabinoids: Commercial Promises vs. Scientific Evidence

Minor cannabinoids like CBG, CBN, CBC, THCV, and CBDV are increasingly marketed in oils, gummies, and supplements with claims ranging from improved sleep to appetite control. However, a guide from Rare Cannabinoid Company highlights a significant gap between commercial marketing claims and actual human clinical evidence. While these compounds show promise in preclinical studies, rigorous human trials remain limited for most applications. Consumers in Puerto Rico should approach these products with caution and consult healthcare providers before use. As the market expands, regulatory oversight and evidence-based research become increasingly important for patient safety.

2 hours ago
Revista Cáñamo
Medical Cannabis Registered in Spain, but Patient Access Remains Delayed
Cannabis
Chronic PainEpilepsy

Medical Cannabis Registered in Spain, but Patient Access Remains Delayed

Spain's first standardized medical cannabis preparations have been officially registered for over two months, yet hospitals have not begun acquiring or dispensing them to patients. This gap between regulatory approval and clinical implementation highlights ongoing challenges in the European medical cannabis rollout. The delay raises concerns for patients with conditions like chronic pain, epilepsy, and multiple sclerosis who could benefit from these treatments. Healthcare officials must clarify timelines and distribution protocols to ensure patients can access these medications. This situation reflects broader implementation barriers across European healthcare systems transitioning to regulated cannabis therapeutics.

3 hours ago
Revista Cáñamo
California Expands Cannabis Product Recalls Over Pesticide Violations
Cannabis

California Expands Cannabis Product Recalls Over Pesticide Violations

California's Department of Cannabis Control has removed four cannabis products from the market due to pesticide residue violations and unsanitary cultivation conditions. The enforcement action coincides with an ongoing investigation into a worker's death in Lake County, though no public forensic determination has yet linked the fatality to specific pesticide exposure. These recalls highlight the critical importance of rigorous quality control and regulatory oversight in the legal cannabis supply chain to protect consumers and workers from contaminated products. The incident underscores ongoing challenges in ensuring product safety standards across cultivation and processing facilities. For medical cannabis patients in Puerto Rico and elsewhere, these recalls serve as a reminder of the necessity for purchasing only from licensed, regulated dispensaries that maintain strict testing protocols.

3 hours ago
Revista Cáñamo
Portugal's 25 Years of Drug Decriminalization: A Public Health Model for Reducing Overdose Deaths
Cannabis
AnxietyDepression

Portugal's 25 Years of Drug Decriminalization: A Public Health Model for Reducing Overdose Deaths

Portugal's quarter-century approach to drug decriminalization demonstrates that treating drug use as a public health issue rather than a criminal one saves lives. By prioritizing treatment access, healthcare integration, and social support systems, Portugal significantly reduced overdose deaths and addiction rates. In contrast, nearly 70,000 Americans died from drug overdoses in 2025, highlighting the urgent need for similar public health investments. Experts emphasize that effective harm reduction requires sustained commitment to connecting people with comprehensive medical and social services, offering valuable lessons for U.S. drug policy reform.

20 hours ago
Marijuana Moment